<p>Proportion of people starting HAART at CD4 count ≤100 cells/mm3 who failed first-line therapy and time to treatment failure (days) comparing 2NRTIs+NNRTI with 2NRTIs+PI<sub>boosted</sub> first-line regimens.</p
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
<p>Magnitude of follow-up CD4 cell count by demographic and baseline treatment variables among patie...
Background. Although the kinetics of CD4+ cell counts have been extensively studied in antiretrovira...
<p>Proportion of people starting HAART at CD4 count 201 – 350 cells/mm3 ...
<p>Proportion of people starting HAART at CD4 count >350 cells/mm3 who f...
<p>Estimated time-to-first-line 2NTRIs+NNRTI or 2NRTIs+PI<sub>boosted</sub> treatment failure and co...
<p>Proportion of PLHIV starting 2NTRIs+NNRTI or 2NRTIs+PI<sub>boosted</sub> with CD4≤200 cells/mm3 a...
Objective: Treatment guidelines recommend initiation of therapy for individuals experiencing rapid ...
<p>Mean CD4<sup>+</sup> T-cell percentage (95% confidence interval) after ART initiation by regimen....
BACKGROUND: Although HIV treatment guidelines recommend highly active antiretroviral therapy (HAART)...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...
OBJECTIVES: To compare the response to highly active antiretroviral therapy (HAART) in individuals s...
<p>*Reference category.</p><p>**Others included injecting drug use, transfusion and unrecorded.</p>#...
Background: Changes in CD4 cell counts are poorly documented in individuals with low or moderate-lev...
Abstract OBJECTIVES: To compare the response to highly active antiretroviral therapy (HAART) in indi...
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
<p>Magnitude of follow-up CD4 cell count by demographic and baseline treatment variables among patie...
Background. Although the kinetics of CD4+ cell counts have been extensively studied in antiretrovira...
<p>Proportion of people starting HAART at CD4 count 201 – 350 cells/mm3 ...
<p>Proportion of people starting HAART at CD4 count >350 cells/mm3 who f...
<p>Estimated time-to-first-line 2NTRIs+NNRTI or 2NRTIs+PI<sub>boosted</sub> treatment failure and co...
<p>Proportion of PLHIV starting 2NTRIs+NNRTI or 2NRTIs+PI<sub>boosted</sub> with CD4≤200 cells/mm3 a...
Objective: Treatment guidelines recommend initiation of therapy for individuals experiencing rapid ...
<p>Mean CD4<sup>+</sup> T-cell percentage (95% confidence interval) after ART initiation by regimen....
BACKGROUND: Although HIV treatment guidelines recommend highly active antiretroviral therapy (HAART)...
OBJECTIVE:Treatment guidelines recommend initiation of therapy for individuals experiencing rapid CD...
OBJECTIVES: To compare the response to highly active antiretroviral therapy (HAART) in individuals s...
<p>*Reference category.</p><p>**Others included injecting drug use, transfusion and unrecorded.</p>#...
Background: Changes in CD4 cell counts are poorly documented in individuals with low or moderate-lev...
Abstract OBJECTIVES: To compare the response to highly active antiretroviral therapy (HAART) in indi...
Background : Estimation of CD4 cell count remains the primary monitoring tool in assessing efficacy ...
<p>Magnitude of follow-up CD4 cell count by demographic and baseline treatment variables among patie...
Background. Although the kinetics of CD4+ cell counts have been extensively studied in antiretrovira...